CJC-1295 (DAC)
A long-acting growth-hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
Mod GRF (1-29) is a modified synthetic analog of growth hormone-releasing hormone (GHRH) with an extended half-life. It is studied for its ability to stimulate the pulsatile release of growth hormone without disrupting natural rhythms.
In the literature, Mod GRF (1-29) appears most often in work focused on growth hormone, muscle growth and recovery. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.
Because it is catalogued here under powder peptides, Mod GRF (1-29) also shows up in discussions of cellular repair. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.
Tap a topic to see which peptides are most studied for it.
A long-acting growth-hormone-releasing hormone analog studied for sustained GH and IGF-1 elevation.
A synergistic GH stack studied for muscle recovery, sleep quality, and body composition.
A shorter-acting GHRH analog studied for pulsatile, more natural GH release patterns.
Research use only. This page summarizes areas of published study and is not medical advice. No dosing, protocol, or usage guidance is provided.